New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas

New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas

Relevance. Cutaneous T-cell lymphomas (CTCL) are not common diseases which are associated with a decrease in quality of life. Currently available systemic therapy rarely provides a stable and long-termed response. In Russia, current CTCL therapy is a big issue due to the limited access to modern tar...

Full description

Bibliographic Details
Main Authors: Irina V. Poddubnaya, Vadim V. Ptushkin, Irena E. Belousova, L. G. Gorenkova, Kamil D. Kaplanov, A. E. Karamova, Alla M. Kovrigina, O. A. Kolomeitsev, T. S. Konstantinova, Muza M. Kokhan, Tatyana I. Pospelova
Format: Article
Language:Russian
Published: IP Habib O.N. 2020-07-01
Series:Современная онкология
Subjects:
brentuximab vedotin
cd30 + primary cutaneous t-cell lymphoma
mycosis fungoides
sézary syndrome
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/34929/23348

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/34929/23348

Similar Items